Production of fungal chitosan by solid state and submerged fermentation

by Nwe, N., Chandrkrachang, S., Stevens, W.F., Maw, T., Tan, T.K., Khor, E., Wong, S.M.
Published 2014

Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource-limited settings: Week 104 analysis of AIDS clinical trials group (ACTG) A5230

by Kumarasamy N., Aga E., Ribaudo H., Wallis C., Katzenstein D., Stevens W., Norton M., Klingman K., Hosseinipour M., Crump J., Supparatpinyo K., Badal-Faesen S., Bartlett J.
Published 2015

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

by Bartlett J., Ribaudo H., Wallis C., Aga E., Katzenstein D., Stevens W., Norton M., Klingman K., Hosseinipour M., Crump J., Supparatpinyo K., Badal-Faesen S., Kallungal B., Kumarasamy N.
Published 2017

Perinatal risk factors for sensitization, atopic dermatitis and wheezing during the first year of life (PIPO study)

by Hagendorens, M.M., Bridts, C.H., Lauwers, K., Van, Nuijs S., Ebo, D.G., De, Clerck L.S., Stevens, W.J., Vellinga, A., Weyler, J.J., Van, Bever H.P.
Published 2013

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phas...

by Tang M.W., Rhee S.-Y., Bertagnolio S., Ford N., Holmes S., Sigaloff K.C., Hamers R.L., De Wit T.F.R., Fleury H.J., Kanki P.J., Ruxrungtham K., Hawkins C.A., Wallis C.L., Stevens W., Van Zyl G.U., Manosuthi W., Hosseinipour M.C., Ngo-Giang-Huong N., Belec L., Peeters M., Aghokeng A., Bunupuradah T., Burda S., Cane P., Cappelli G., Charpentier C., Dagnra A.Y., Deshpande A.K., El-Katib Z., Eshleman S.H., Fokam J., Gody J.-C., Katzenstein D., Koyalta D.D., Kumwenda J.J., Lallemant M., Lynen L., Marconi V.C., Margot N.A., Moussa S., Ndung'U T., Nyambi P.N., Orrell C., Schapiro J.M., Schuurman R., Sirivichayakul S., Smith D., Zolfo M., Jordan M.R., Shafer R.W.
Published 2014

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Paci...

by Hamers R., Oyomopito R., Kityo C., Phanuphak P., Siwale M., Sungkanuparph S., Conradie F., Kumarasamy N., Botes M., Sirisanthana T., Abdallah S., Li P., Ngorima N., Kantipong P., Osibogun A., Lee C., Stevens W., Kamarulzaman A., Derdelinckx I., Chen Y., Schuurman R., Van vugt M., Rinke de wit T., Njovu C., Labib M., Menke J., Sanne I., Wallis C., Hardman M., Wellington M., Luthy R., Mandaliya K., Jao I., Dolan M., Namayanja G., Nakatudde L., Kiconco M., Abwola M., Mugyenyi P., Ndembiz N., Kaleebu P., Akanmu S., Wensing A., Sigaloff K., Straatsma E., Lee M., Wong K., Saghayam S., Pujari S., Joshi K., Merati T., Yuliana F., Low L., Ong L., Mustafa M., Nordin N., Ditangco R., Bantique R., Wong W., Yang Y., Sirivichayakul S., Piyavong B., Praparattanapan J., Kambua P., Choi J., Han S., Ratanasuwan W., Sriondee R., Kantor R., Sohn A., Messerschmidt L., Singtoroj T., Cooper D., Law M., Jiamsakul A., Zhou J.
Published 2017